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Background: DFF40/CAD mediates nuclear fragmentation and oligonucleosomal DNA degradation during
apoptosis.
Results:DFF40/CAD overexpression allows apoptotic-defective LN-18 cells to display internucleosomal DNA degradation but
not chromatin disassembly upon cytotoxic insult.
Conclusion: DFF40/CAD can induce DNA laddering in the absence of apoptotic chromatin disassembly.
Significance: Dissecting DFF40/CAD regulation may shed light on some of the apparent non-desirable tumor responses in
currently used anti-cancer therapies.
Caspase-dependent apoptosis is a controlled type of cell death
characterized by oligonucleosomal DNA breakdown and major
nuclear morphological alterations. Other kinds of cell death do
not share these highly distinctive traits because caspase-acti-
vated DNase (DFF40/CAD) remains inactive. Here, we report
that human glioblastoma multiforme-derived LN-18 cells do
not hydrolyze DNA into oligonucleosomal fragments after apo-
ptotic insult. Furthermore, their chromatin remains packaged
into a singlemass, with no signs of nuclear fragmentation. How-
ever, ultrastructural analysis reveals that nuclear disassembly
occurs, although compacted chromatin does not localize into
apoptotic nuclear bodies. Caspases become properly activated,
and ICAD, the inhibitor of DFF40/CAD, is correctly processed.
Using cell-free in vitro assays, we show that chromatin from
isolated nuclei of LN-18 cells is suitable for hydrolysis into oligo-
nuclesomal fragments by staurosporine-pretreated SH-SY5Y
cytoplasms. However, staurosporine-pretreated LN-18 cyto-
plasms do not induce DNA laddering in isolated nuclei from
either LN-18 or SH-SY5Y cells because LN-18 cells express
lower amounts of DFF40/CAD. DFF40/CAD overexpression
makes LN-18 cells fully competent to degrade their DNA into
oligonucleosome-sized fragments, and yet they remain unable
to arrange their chromatin into nuclear clumps after apoptotic
insult. Indeed, isolated nuclei fromLN-18 cells were resistant to
undergoing apoptotic nuclear morphology in vitro. The use of
LN-18 cells has uncovered a previously unsuspected cellular
model, whereby a caspase-dependent chromatin package is
DFF40/CAD-independent, and DFF40/CAD-mediated double-
strand DNA fragmentation does not warrant the distribution of
the chromatin into apoptotic nuclear bodies. The studies high-
light a not-yet reported DFF40/CAD-independent mechanism
driving conformational nuclear changes during caspase-depen-
dent cell death.
Apoptosis is a genetically controlled cell death program in
which the condensation of the nucleus and its fragmentation
into smaller pieces are the most noticeable features. Another
typical trait of apoptotic cell death is the extensive hydrolysis of
nuclear DNA into oligonucleosome-sized fragments. These are
highly distinctive events (hallmarks) of apoptosis, and no other
types of cell death provoke such cellular alterations (1). The
nuclei of cells committed to apoptosis undergo different ultra-
structural stepwise modifications. In the first stage, chromatin
condenses around the nuclear membrane, known as stage I
chromatin condensation or stage I nuclear morphology (2).
Later nuclear changes include shrinkage and fragmentation of
the nucleus into highly packed round masses of condensed
chromatin (3, 4), also known as stage II chromatin condensa-
tion (2). In parallel, the genomic content is extensively frag-
mented in a two-step process, in which the DNA is first cleaved
into 50–300-kilobase pair (kbp) fragments, an event also
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known as high molecular weight (HMW)6 DNA degradation,
followed by hydrolysis into smaller fragments of oligonucleo-
somal size, also called “DNA ladder” (5, 6). The molecular
machinery involved in the apoptotic hallmarks is a family of
cysteine proteases called caspases. Caspases can be broadly
classified into “initiator” (caspase-2, -8, -9, and -10) or “effector”
caspases (caspase-3, -6, and -7) (7). After direct activation by
initiator caspases, effector caspases execute limited proteolysis
of downstream specific substrates, triggering a cascade of
events thatwill dismantle the cell (8). The inhibition of caspases
in damaged cells avoids cell death aswell as apoptotic hallmarks
(9, 10).Whereas HMW DNA degradation and stage I nuclear
morphology are caspase-independent events (10), oligonucleo-
somal DNA degradation together with stage II nuclear mor-
phology are considered the hallmarks of caspase-dependent
apoptosis (11). The main protein triggering the two hallmarks
of apoptotic cell death downstreamof the activation of caspases
is a nuclease called DNA fragmentation factor 40-kDa subunit
(DFF40) (12) or caspase-activated nuclease (13) in humans, or
caspase-activated DNase (CAD) (14) in mice. DFF40/CAD
remains inactive when combined with its chaperone-inhibitor,
ICAD (15), also known as DNA fragmentation factor, 45-kDa
subunit (DFF45) (5). After apoptotic insult, active caspase-3
processes ICAD into two aspartic residues, Asp-117 and Asp-
224, in both long (DFF45/ICADL) and short (DFF35/ICADS)
splicing variants (5). The hydrolysis of DFF45/ICADL in these
two residues allows the release and activation of DFF40/CAD
(12, 15). The DNA laddering appears after DFF40/CAD-medi-
ated DNA hydrolysis at internucleosomal sites (12–14). Many
approaches have been used to unravel the molecular mecha-
nisms implicated in the onset and progression of apoptotic
nuclear morphology and DNA degradation during apoptosis.
Classically, stage II chromatin condensation and oligonucleo-
somal DNA degradation were considered concomitant events
(16–19). DFF40/CAD activity still remains as the key biochem-
ical feature triggering both apoptotic nuclear changes andDNA
laddering. Yet, some cellular models, in which stage II nuclear
morphology occurs in the absence of DNA laddering, have
recently pointed out that these two apoptotic hallmarks can be
dissociated (20–23). Moreover, no cellular models have so far
been reported showing the presence of DNA ladder in the
absence of nuclear disassembly following caspase-dependent
apoptotic cell death.
In this study, we report on a glioblastoma multiforme-de-
rived human cell line, LN-18 cells, in which apoptotic stimuli
induce caspase-dependent cell death, characterized by a single
mass of highly compacted chromatin without displaying either
oligonucleosomal DNA degradation or stage II nuclear mor-
phology. The poor expression of DFF40/CAD endonuclease
seems to be the reason why LN-18 cells cannot generate DNA
laddering after apoptotic stimuli, as the overexpression of the
nuclease is sufficient to make these cells fully competent to
degrade DNA into oligonucleosome-sized fragments. Interest-
ingly, we show that higher levels ofDFF40/CAD failed to induce
stage II apoptotic nuclearmorphology after caspase-dependent
cytotoxic insult. Moreover, by using cell-free assays, we dem-
onstrate that LN-18 isolated nuclei cannot display apoptotic
nuclear alterations. Altogether, our results show, for the first
time, that DFF40/CAD is necessary and sufficient to generate
DNA laddering, but not sufficient to provoke nuclear disassem-
bly during apoptosis, and other players seem to be needed.
EXPERIMENTAL PROCEDURES
Reagents—All chemicals were obtained from Sigma-Aldrich
unless otherwise indicated. The pan-caspase inhibitor q-VD-
OPh was fromMP Biomedicals Europe (Illkirch, France). Anti-
bodies against caspase-3 (9662; 1:2,000) and caspase-7 (9492;
1:2,000) were purchased from Cell Signaling Technology (Bev-
erly, MA). Antibodies against DFF40/CAD (AB16926, 1:500)
and -fodrin (clone AA6) (MAB1622; 1:40,000) were obtained
from Millipore. Antibodies against caspase-6 (clone 3E8)
(M070-3; 1:2,000) and DFF45/ICAD (clone 6B8) (M037-;
1:40,000)were fromMBL (Naka-kuNagoya, Japan). Anti-lamin
A/C (clone JOL2) (Ab40567; 1:2,000) was from Abcam
(Cambridge, UK). Anti-p23 antibody (clone JJ3) (NB300-576;
1:10,000) was obtained from Novus Biological Europe, Inc.
(Cambridge, UK). Horseradish peroxidase-conjugated second-
ary antibodies against mouse IgG (A9044; 1:20,000) or rabbit
IgG (A0545; 1:20,000) were purchased from Sigma. The cyto-
toxic drugs used were actinomycin D (50 M as lethal dose, 40
nM as a sublethal dose), cytosine arabinoside (2,500 g/ml),
azacytidine (100 M); bevacizumab (500 g/ml), camptothecin
(100M), ceramide-2 (50M), ceramide-8 (50M), cisplatin (50
g/ml), colchicine (50 M), curcumin (100 M), cycloheximide
(100M), diamide (750M), doxorubicin (100M), epigallocat-
echin (500 M), ergocalciferol (100 M), etoposide (100 M),
5-fluorouracil (1000 M), gencitabine (300 M), GW4869 (100
M), rinotecan (500 M), methotrexate (500 M), MG132 (20
M), nocodazole (100 M), oxaliplatin (100 g/ml), paclitaxel
(50 M), rotenone (100 M), staurosporine (STP, 1 M), temo-
zolomide (50 M), vinblastine (25 M), CH11 (0.1 g/ml),
TNF (0.1 g/ml), and TRAIL (0.1 g/ml).
Cell Lines and Culture Procedures—IMR-5, LN-18, and
SH-SY5Y cells were routinely grown in 100-mm culture dishes
(BD Falcon, Madrid, Spain) containing 10 ml of Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with penicil-
lin/streptomycin (100 units/ml and 100 g/ml, respectively)
and 10% of heat-inactivated fetal bovine serum (FBS) (Invitro-
gen). Medium was routinely changed every 3 days. Cells were
maintained at 37 °C in a saturating humidity atmosphere con-
taining 95% air and 5% CO2.
Chromatin Staining with Hoechst 33258 and Trypan Blue
Exclusion Assays—Nuclear morphology staining with Hoechst
33258 and trypan blue assays were performed as established
previously in our laboratory (24). Cell nuclei were visualized
with a Nikon ECLIPSE TE2000-E microscope equipped
with epifluorescence optics under UV illumination and a
Hamamatsu ORCA-ER photographic camera. Stained nuclei
6 The abbreviations used are: HMW, high molecular weight; CAD, caspase-
activated DNase; DEVD, Asp-Glu-Val-Asp DFF40/CAD, DNA fragmentation
factor, 40-kDa subunit; DFF45, DNA fragmentation factor, 45-kDa subunit;
ICAD, inhibitor of CAD; LDH, lactate dehydrogenase; LMW, low molecular
weight; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide; qVD, Q-VD-OPh, N-(2-quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)-
methyl ketone; STP, staurosporine; TRAIL, TNF-related apoptosis-
inducing ligand.
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were scored as stage I (partial chromatin condensation in the
absence of karyorrhexis), stage II (nuclear pyknosis and karyor-
rhexis), or stage III (nuclei shrinkage and highly compacted
chromatin) morphology (10).
Cell Viability through MTT Reduction Assay—MTT is a
water-soluble tetrazolium salt that can be reduced only bymet-
abolically viable cells. The result is a colored water-insoluble
formazan salt. This technique was performed as described pre-
viously (18).
Cell Death through Lactate Dehydrogenase (LDH) Release
Assay—The measure of extracellular LDH was performed by a
modified protocol from Decker and Lohmann-Matthes (25).
Cells were seeded in a 96-multiwell plate at 50% confluence the
day before treatment. Then, medium was replaced by 50 l of
fresh medium containing or not 1 M STP. 24 h later, 20 l of
lactate solution (14.38 mg/ml in 10mMTris buffer, pH 8.5) was
added, followed by 20l of INT solution (0.9mg/ml INT in PBS
prepared from a 20 mg/ml stock solution in dimethyl sulfox-
ide). The enzymatic reaction was started by addition of 20l of
a PBS solution containing NAD (1.65 mg/ml), diaphorase
(7107 units/ml), BSA (0.015%), and sucrose (0.6%) and al-
lowed to proceed for 20 min. The reaction was stopped by the
addition of 20 l of the LDH inhibitor oxamate (5.6 mg/ml in
PBS). Absorbance was measured by using a 490 nm filter in a
BIO-TEK FL800 fluorometer (Izasa, Spain). The percentage of
LDH activity in the culture medium was calculated taking into
account the LDH activity obtained from non-treated cells per-
meabilized with a solution containing 1% Triton X-100,
assumed as 100% of LDH activity.
Low Molecular Weight (LMW) or Oligonucleosomal DNA
Degradation Analysis—LMW analysis was carried out as
described previously (26). Extracted DNAwas analyzed in 1.8%
agarose gel in 1 mM EDTA, 40 mM Tris acetate, pH 7.6, stained
in 0.5 g/ml ethidium bromide, and then visualized using a
Syngene Gene Genius UV transilluminator equipped with a
photographic camera.
HMW DNA Fragmentation Analysis—Detection of HMW
fragments was made as described previously (23). The gel was
electrophoresed at room temperature for 16 h at 45 V. Follow-
ing electrophoresis, the gel was stained in 2 g/ml ethidium
bromide for 2 h and washed twice with distilled water for 30
min. DNA was visualized using a Syngene Gene Genius UV
transilluminator coupled with a photographic camera.
Transmission Electron Microscopy—Transmission electron
microscopy was used to examine the nuclear morphology of
IMR-5, SH-SY5Y, and LN-18 cells as well as LN-18 cells trans-
fected with pcDNA3.1 containing or not the open reading
frame of the human CAD. Stably transfected cells were left
untreated or treated with staurosporine for 10 h. Cells were
then collected and fixed with 2.5% (v/v) glutaraldehyde and 2%
(v/v) paraformaldehyde (EM grade, Merck, Darmstadt, Ger-
many) in phosphate buffer (100 mM, pH 7.4). After fixation,
pellets were rinsed four times with phosphate buffer and post-
fixed in 1% (w/v) osmium tetroxide (TAAB Laboratories, Berk-
shire, UK) containing 0.8% (w/v) potassium hexacyanoferrate
(III) (Sigma) for 2 h. After four washes with deionized water,
pellets were sequentially dehydrated in acetone. All of these
steps were performed at 4 °C. Samples were then embedded in
Eponate 12TM resin (Ted Pella Inc., Redding, CA) and poly-
merized for 48 h at 60 °C. Ultrathin (70 nm thick) sections were
placed on noncoated copper grids (200 meshes), contrasted
with uranyl acetate and lead citrate solutions, and visualized
with a transmission electron microscope (Jeol JEM-1400)
equipped with a CCD GATAN ES1000W Erlangshen camera.
DEVD-directed Caspase Activity—Quantitative DEVD-like
activities in cell lysates were performed as described previously
(27). The resulting 96-multiwellmicroplateswere incubated for
10 h at 35 °C. The data were obtained by using a BIO-TEK
Synergy HT fluorometer, under an excitation filter of 360 nm
(40-nm bandwidth) and an emission filter of 530 nm (25-nm
bandwidth).
Protein Extractions and Western Blotting—Cells were de-
tached, pelleted at 600  g for 5 min, and washed once with
PBS. Then cells were lysed 15 min on ice with Igepal buffer (50
mM Tris-HCl, pH 6.8, 1 mM EDTA, 150 mM NaCl, 1% Igepal
CA-630, 1 protease inhibitor cocktail (Sigma)) for cytosolic
protein extracts. The pellets were clarified by centrifuging at
16,000 g for 5 min at 4 °C. Alternatively, cells were lysed with
SET buffer (10 mM Tris-HCl, pH 6.8, 150 mM NaCl, 1 mM
EDTA, 1% SDS) and heated at 95 °C for 10 min to obtain total
protein extracts. The protein concentration in the supernatants
was quantified by a modified Lowry assay (DC protein assay;
Bio-Rad), and 20–35 g of protein was loaded in SDS-poly-
acrylamide gels. Proteins were electrophoresed and electro-
transferred onto polyvinylidene difluoride (PVDF) Immobilon-
P membrane (Millipore) or Protran nitrocellulose transfer
membrane (Whatman). After blocking with Tris-buffered
saline (TBS), 0.1%Tween 20 containing 5% nonfat drymilk, the
membranes were probed with the appropriate specific primary
antibodies and incubatedwith the adequate secondary antibod-
ies conjugated with peroxidase. Finally, immunoblots were
developed by EZ-ECL chemiluminescence detection kit (Bio-
logical Industries, Kibbutz Beit-Haemek, Israel).When the spe-
cific antibodies were blotted, themembranes were stained for 5
min in a solution containing 10%methanol, 2% acetic acid, and
0.1% naphthol blue. Then, membranes were destained in a 10%
methanol and 2% acetic acid solution for 10 min. Membranes
were allowed to dry and were scanned.
Sequencing of DFF45/ICADL, DFF35/ICADS, and DFF40/
CAD from LN-18 Cells—mRNA was isolated from untreated
LN-18 cells using the RNeasy kit (Qiagen) according to the
manufacturer’s instructions, employing for the extraction the
RLN buffer (50 mM Tris-HCl, pH 8.0, 140 mM NaCl, 1.5 mM
MgCl2, 0.5% Igepal CA-630, 1,000 units/ml RNase inhibitor, 1
mM DTT). Two micrograms of RNA was reverse-transcribed
(Transcriptor First Strand cDNA Synthesis kit; Roche Applied
Science) using 10 pmol of random hexamer primer or the spe-
cific downstream primer (CAD-R; see below) for 30 min at
65 °C. Two microliters of cDNA was amplified by polymerase
chain reaction in an Applied Biosystem thermal cycler 2720
with 300 nM for each primer. The polymerase chain reaction
conditions were 95 °C for 20 s, 56 °C for 10 s, and 70 °C for 24 s,
repeated 30 cycles in 1.5 mMMgSO4, 200 nM each dNTP, and 1
unit of KOD Hot Start DNA polymerase (Merck). For amplify-
ing DFF40/CAD the following primers were used: CAD-F,
5-CAGAGGGCTTGAGGACAT-3 and CAD-R, 5-TCAGG-
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CCTCAAACAAAGACCAGGA-3. The 1,017-base pair am-
plified cDNAwas automatically sequenced in both directions in
a 3130XL genetic analyzer (Applied Biosystems) corresponding
to the whole ORF of human DFF40/CAD (GenBankTM ac-
cession number NM_004402). For amplifying DFF45/ICADL the
following primers were used: EcoRI-ICAD-F, 5-GGAATTCG-
GTCCCACCTTGTGGAGGAT-3 and EcoRI-ICAD-R, 5-
GGAATTCGAGGCTGAGGGTGTCTACCA-3. The 996-
base pair cDNA obtained, corresponding to the whole ORF
of human DFF45/ICADL (GenBankTM accession number
NM_004401), was also sequenced in both directions. Finally,
for amplifying DFF35/ICADS the following primers were used:
EcoRI-ICAD-F, 5-TGAATTCCACCTCTGCATGATACTA-
CTACATCC-3 and EcoRI-ICADS-R 5-CCGCTCGAGCAG-
GGCATGTCCTCCTCTGTAG-3. The 807-base pair cDNA
obtained, corresponding to the whole ORF of human DFF35/
ICADS (GenBankTM accession number NM_213566), was also
sequenced in both directions.
Cell-free System to Detect DNA Degradation—Cytoplasms
and nuclei from LN-18 and SH-SY5Y cells were prepared as
established previously in our laboratory (23). Each reaction was
carried out employing 150g of cytosolic extract and 105 nuclei
and stopped by adding 5 mM EDTA after 2 h. Then, reactions
were centrifuged for 15min at 16,000 g, at 4 °C. Supernatants
were collected and DNA extracted to discard the LMW DNA
fragments as potential contaminant from staurosporine-pre-
treated SH-SY5Y cytoplasms. The pelleted nuclei were washed
once with cytosolic extraction buffer (20 mM Tris-HCl, pH 7.4,
10 mM KCl, 2 mM MgCl2, 1 mM DTT, 0.5 mM EGTA, 2.5%
glycerol, 0.5% Igepal CA-630) obtaining the “nuclei wash” frac-
tion that was also DNA-extracted to further ascertain both the
absence of DNA after nuclei wash and the purity of the pelleted
nuclei. Finally, pelleted nuclei were resuspended in bi-distilled
water and processed according to the oligonucleosomal DNA
degradation analysis procedure.
Transfection of DFF40/CAD—LN-18 cells were transfected
with the eukaryotic expression vector pcDNA3.1 containing or
not the open reading frame of the human CAD by using Lipo-
fectamine 2000 Reagent and according to manufacturer’s pro-
tocol. Transient transfection was analyzed 24 h after transfec-
tion. To obtain stably transfected cells, 24 h after transfection,
cells were grown in selective medium containing 1 mg/ml
G-418 (Geneticin) (Invitrogen) for 25–30 days (until non-
transfected cells died in selective medium) and used as a pool.
Cell-free System to Analyze Nuclear Morphology—To obtain
isolated nuclei, SH-SY5Yor LN-18 cells were cultured into 6-
100-mm culture dishes. After confluence, cells were collected
and centrifuged at 500 g for 5 min. Pelleted cells were rinsed
oncewith PBS and resuspended in 5 volumes of cell-free extrac-
tion buffer (20 mM Hepes-KOH, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM DTT) supplemented with 0.2% (for SH-SY5Y
cells) or 0.4% (for LN-18 cells) Igepal CA-630. The resuspended
cells were kept on ice for 30 min before passing through a
22-gauge syringe (20 times for SH-SY5Y cells or 30 times for
LN-18 cells). Then, nuclei were pelleted at 8,000 g for 10min,
resuspended in 700 l of cell-free extraction buffer containing
0.5 M sacarose and carefully layered on the top of 700 l of
cell-free extraction buffer containing 1.5 M sacarose. After cen-
trifugation at 8,000  g for 10 min, the supernatants were dis-
carded, and pelleted nuclei were washed once with cell-free
extraction buffer. Purified nuclei were first resuspended in 2
nuclear storage buffer (20 mM Pipes, pH 7.5, 160 mM KCl, 40
mMNaCl, 10mMEGTA, 2mMDTT, 0.5M sacarose), and finally,
the same volume of glycerol was added. Aliquots of 5  107
nuclei/ml were prepared and stored at 80 °C until use. To
obtain cytosolic extracts, SH-SY5Y or LN-18 cells were treated
with 1 M STP for 24 h or left untreated. Cells were collected
and centrifuged at 500 g for 5min, rinsed once with PBS, and
resuspended in 4 volumes of cell-free extraction buffer supple-
mented with 1 mM PMSF. After 15 min on ice, SH-SY5Y and
LN-18 lysates were passed through a 22-gauge syringe 20 or 30
times, respectively. The obtained lysates were purified by
means of serial centrifugations at 3,000 g for 5 min, 16,000
g for 5 min, and 100,000 g for 1 h. Finally, aliquots of 100 g
of protein were prepared and stored at 80 °C until use. To
perform the cell-free assay, 6 105 isolated nuclei and 100 g
of RNA-free cytoplasms (obtained after incubation with 100 ng
of RNase at room temperature for 10 min) were employed for
each reaction. Each cell-free in vitro assaywas carried out under
mild agitation (350 rpm) at 35 °C in a buffer containing 25 mM
Pipes, pH 7.5, 150 mM KCl, 5 mM MgCl2, 1 mM DTT supple-
mented with an ATP regeneration system (40 MATP, 200 M
phophocreatine, 1 g/ml creatine phosphokinase). The final
volume of each reaction was adjusted to 143 l with cell-free
extraction buffer. After the indicated times, the reactions were
stopped by adding 1% paraformaldehyde. Nuclei were stained
with 0.5 g/ml Hoechst 33258 and visualized under UV illumi-
nation with epifluorescence optics. Representative images of
each condition were obtained as aforementioned.
RESULTS
LN-18 Cells Do Not Display Apoptotic Nuclear Features after
Staurosporine Treatment—We have previously addressed the
molecular and biochemical mechanisms that govern the final
steps during cell death by analyzing the nuclear outcomes in
different tumor-derived cells exposed to apoptotic insults.
Indeed, we have described two main cellular caspase-depen-
dent responses to staurosporine treatment, a broad kinase
inhibitor and a well known apoptotic inductor. First, the alka-
loid induced a canonical apoptotic response when added to the
culture medium of SH-SY5Y cells, including oligonucleosomal
DNA degradation and stage II nuclear morphology. However,
IMR-5 cells did not display internucleosomal DNA cleavage or
stage II nuclear morphology after apoptotic injury (18). Here,
we report a new cellular paradigm of apoptotic cell death
depicted by the glioblastoma multiforme-derived LN-18 cells.
After staurosporine treatment, SH-SY5Y, IMR-5, and LN-18
cells showed comparable percentages of cell death, reaching
86.80%, 92.04%, and 81.95% of trypan blue-positive cells,
respectively (Fig. 1A, left). However, the nuclear aspect dis-
played by these cells was dissimilar. As expected, and after stau-
rosporine treatment, SH-SY5Y cells underwent stage II nuclear
morphology, and IMR-5 cells displayed stage I nuclear mor-
phology (Fig. 1B, and A, right). Nevertheless, LN-18 cells
showed a prominent nuclear pyknosis without karyorrhexis
(Fig. 1B, and A right), compatible with stage III nuclear mor-
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phology (10). This particular outcomewas observed at any time
during the treatment with staurosporine (Fig. 1C), ruling out
the possibility that LN-18 cells could display stage I and/or
stage II nuclear morphology throughout cell death. The differ-
ences in nuclear changes induced by staurosporine were also
corroborated by electron microscopy (Fig. 2). In IMR-5 cells
(Fig. 2, top), staurosporine induced disruption of intracellular
structural organization, including mitochondrial swelling and
fragmentation of the rough endoplasmic reticulum. Uneven
condensed marginal chromatin appeared homogeneously dis-
tributed inside the nucleus, forming irregular and intercon-
nectedmasses of chromatin in a coarse pattern. Although chro-
matin condensation was the main nuclear change observed, its
texture, shape, and distribution pattern differed from the typi-
cal apoptotic images found in SH-SY5Y (Fig. 2, middle). The
nucleus from staurosporine-treated SH-SY5Y cells contained
FIGURE 1. LN-18 cells do not display apoptotic hallmarks during staurosporine-triggered cell death. IMR-5, LN-18, and SH-SY5Y cells were seeded as
described under “Experimental Procedures” and treated with 1 M staurosporine (STP or) or left untreated (Control or). A, cell death was measured by
trypan blue exclusion assay after cells were treated for 24 h. Blue (dead) cells are represented over total (blue and white) cells. The graphic represents the
means  S.D. (error bars) of 300 cells from three independent experiments. B, nuclear morphology was assessed by fixing cells and staining nuclei with
Hoechst 33258, 24 h after treatment. Representative images of each condition are shown. The bottom panels are higher magnifications of the cells framed
in the staurosporine-treated conditions. Scale bar, 40m. C, LN-18 cells were treated with 1M STP for the indicated times (hours). Then, cells were fixed
and stained with Hoechst 33258. Cell death was calculated by counting stage I (peripheral chromatin condensation), stage II (nuclear collapse and
disassembly), or stage III (highly compacted chromatin without signs of karyorrhexis) nuclear morphology. The graph represents the means  S.D.
obtained after counting at least 300 cells for each condition (n  3). D, conventional agarose-gel electrophoresis of DNA to detect oligonucleosomal
DNA fragmentation after 6 h of treatment. E, cells were detached after 4 h of treatment, and genomic integrity was assessed according to the HMWDNA
fragmentation analysis procedure.
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aggregates of highly condensed granular chromatin distributed
beneath the nuclear envelope. The nuclear contour was occa-
sionally misshapen due to protrusions filled with condensed
chromatin that eventually split and formed small rounded bod-
ies surrounded by concentric arrangements of membranes that
presumably arose from the nuclear envelope. The cytoplasmic
matrix appeared highly condensed, and cells adopted smooth
contours (Fig. 2, middle). In the case of LN-18 cells (Fig. 2,
bottom), the integrity of the organelles was not preserved after
staurosporine treatment. Moreover, the alkaloid provoked the
compaction of the nuclear content into a single highly con-
densedmass of chromatin with electron-lucent areas, albeit the
presence of chromatin-free closed loop structures of nuclear
envelope compatible with empty apoptotic nuclear bodies
(arrowheads in Fig. 2, bottom). The intracellular components
were distributed homogeneously throughout the cell, with no
differences between nuclear and cytoplasm content due to the
presence of discontinuities in the nuclear envelope. Finally,
staurosporine-treated LN-18 cells displayed a moderate accu-
mulation of electron-lucent vacuoles, compatible with lipid
FIGURE 2. LN-18 cells present nuclear but not chromatin fragmentation after apoptotic stimuli. Representative images of transmission electronmicros-
copy from IMR-5 (top), SH-SY5Y (middle), or LN-18 (bottom) cells untreated (left) or treatedwith 1M STP for 10 h (right). Arrowheads indicate circular structures
from nuclear envelope, empty of packaged chromatin. Scale bars, 1 m.
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droplets (28). In conclusion, besides subtle cytoplasmic dis-
parities, the most pronounced differences between LN-18
cells and SH-SY5Y or IMR-5 cells were observed at the
nuclear level.
LN-18 Cells Display HMW but Not LMWDNA Degradation
after Staurosporine Treatment—We have shown previously
that SH-SY5Y and IMR-5 cells underwent apoptosis in the
presence or the absence, respectively, of oligonucleosome-sized
DNA fragments (27). As shown in Fig. 1D, staurosporine was
able to induce oligonucleosomal DNAdegradation in SH-SY5Y
cells but not in IMR-5 or LN-18 cells 24 h after treatment. The
absence of LMW DNA fragmentation in LN-18 cells was
observed in both short (up to 24 h) and long (up to 3 days)
treatments (data not shown). However, and as described previ-
ously for SH-SY5Y and IMR-5 cells (10), staurosporine-treated
LN-18 cells degraded their genomic content into large chroma-
tin fragments, also known asHMWDNAdegradation (Fig. 1E).
LN-18 Cells Are Defective in Generating the Apoptotic Hall-
marks after a Panoply of Cytotoxic Insults—To evaluate
whether LN-18 cells can undergo canonical apoptosis, we
treated them with a broad battery of apoptotic inductors (see
“Experimental Procedures”). First, as extrinsic insults, we used
CH-11 (analog of Fas ligand), TNF, and TRAIL. Second, to
switch onto the intrinsic apoptotic pathway we used DNA
FIGURE 3. LN-18 cells do not present apoptotic traits after apoptotic stimuli. LN-18 cells were treated as indicated. A, cell viability was measured by MTT
reduction assay after 24 h of treatment. Values represent the means  S.D. (error bars; n  3). B, nuclear morphology was assessed by fixing cells with
paraformaldehyde and staining nuclei with Hoechst 33258 after 24 h of treatment. Representative images are shown. The insets framed in the images are
higher magnifications of the cells. Scale bar, 40 m. C, DNA was extracted 24 h after treatment, and oligonucleosomal DNA degradation was analyzed by
convectional agarose gel electrophoresis. DNA from staurosporine-treated SH-SY5Y cells (SH) was used as a positive control.
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TABLE 1
Summary of cell viability, apoptotic nuclear morphology, and DNA laddering in LN-18 cells treated with different chemotherapeutic drugs
a Cell viability was measured byMTT assay after treating cells for 24 h. The values represent the means S.D. (n 3). Those under 50% of cell survival are highlighted in red.
b When cell viability was lower than 50%, nuclear morphology (scored as stage I (peripheral chromatin condensation), stage II (nuclear collapse and disassembly), or stage III (highly
compacted chromatin without signs of karyorrhexis)), and DNA laddering were evaluated. Minus () and plus () indicate “not detected” and “detected,” respectively.
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cross-linkers (cisplatin, oxaliplatin), macromolecular synthesis
inhibitors (actinomycin D, cycloheximide), microtubule desta-
bilizing agents (colchicine, nocodazole, paclitaxel, vinblastine),
topoisomerase inhibitors (camptothecin, doxorubicin, etopo-
side, irinotecan), nucleoside analogs (5-fluorouracil, cytosine
arabinoside, azacytidine, gemcitabine), DNA alkylating agents
(temozolomide), oxidizing agents (diamide), among others,
such as bevacizumab (inhibitor of VEGF-A), ceramide-2 and -8
(structural components of cell membrane), curcumin (inhibi-
tor of EGFR and NF-B pathways), ergocalciferol (vitamin D2),
epigallocatechin gallate (inhibitor of VEGF-mediated tyrosine
phosphorylations and Bcl-xL), GW-4869 (inhibitor of neutral
sphingomyelinase), methotrexate (dihydrofolate reductase inhib-
itor), MG132 (inhibitor of proteasome), rotenone (inhibitor of
mitochondrial electron transport chain, complex I) and stauro-
sporine. By means of theMTT reduction assays, we obtained dif-
ferent percentages of cell survival after 24 h of treatment (Fig. 3A
andTable 1). For those drugs that provoked50%of viability loss,
we analyzed the appearance of the nuclei.
According to the nuclear morphology observed, we could
classify the drugs employed into four groups: first, chemother-
apeutics that mostly induced stage I nuclear morphology (such
as cisplatin, curcumin, ergocalciferol, or MG132); second,
drugs that induced stage III (including CH-11 or TRAIL, both
combined with actinomycin D, cycloheximide, paclitaxel, rote-
none, staurosporine, or vinblastine); third, compounds that
induced a mixture of stage I and III (ceramide-8); and fourth,
actinomycin D, diamide, or doxorubicin, which induced loss of
cell viability without major signs of nuclear alterations (Fig. 3B,
and Table 1). It is worth mentioning that none of the cytotoxic
drugs employed was capable of inducing apoptotic stage II
nuclear morphology. Accordingly, none of these compounds
was able to induce the apoptotic degradation of DNA into
oligonucleosome-sized fragments (Fig. 3C and Table 1). Taken
together, these results demonstrate that LN-18 cells do not dis-
play the hallmarks of apoptotic cell death after cytotoxic insult.
LN-18 Cells Undergo Caspase-dependent Cell Death after
Staurosporine Treatment—Because DNA laddering and stage
II nuclearmorphology are the two hallmarks of caspase-depen-
dent apoptosis, we assessed whether LN-18 cells were able to
activate caspases after cytotoxic insult. We used staurosporine
because our preliminary screenings demonstrated that this
alkaloid was the most potent cytotoxic insult. As shown in Fig.
4A, the addition of staurosporine to the culture medium
induced an increase in DEVD-directed caspase activity, first at
2 h after treatment and reached the highest levels at 6 h. Due to
the relevance of executioner caspase-3, -6, and -7 in the cellular
dismantling during apoptosis, wewanted to further confirm the
correct activation of these three proteases. UsingWestern blot-
ting, the processing of caspase-3 to its active p17 fragment was
observed 4 h after staurosporine treatment (Fig. 4B, first panel).
This processing correlated with the cleavage of -fodrin to the
caspase-3-mediated p120 fragment (Fig. 4B, second panel),
confirming the correct activation of this caspase (29). Likewise,
we observed the processing of caspase-6 to its p15 activation
fragment 2 h after staurosporine treatment (Fig. 4B, fourth
panel). The fragmentation of lamins A/C, specific substrates of
activated caspase-6 (30, 31), to the p51/45 fragments, respec-
tively, corroborated the correct activation of this caspase (Fig.
4B, fifth panel). Finally, 4 h after staurosporine treatment, we
detected caspase-7 processing to its active fragment p20 (Fig.
4B, seventh panel). The processing of p23 co-chaperone to a p15
fragment, a specific event mediated by active caspase-7 (32),
FIGURE 4. Executioner caspases become correctly activated after stauro-
sporine treatment in LN-18 cells. LN-18 cells were treated with 1 M stau-
rosporine for 2, 4, 6, or 8 h, or left untreated (0). After treatment, cells were
detached, and proteins extracts were obtained. A, DEVD-like activity was
measured and graphed. B, Western blotting against caspase-3, -6, and -7, and
their specific substrates fodrin, lamin A/C, and co-chaperone p23, respec-
tively, were performed. Caspase-3 (p19 and p17), caspase-6 (p20), and
caspase-7 (p20) activation fragments are indicated. The activation of
caspase-3, -6, or -7 was also corroborated by the detection of p120 (fodrin),
p47/p37 (lamin A/C), and p15 (p23 co-chaperone) proteolytic fragments,
respectively. Naphthol blue (NB) staining served as loading control.
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corroborated the correct activation of this protease after stau-
rosporine treatment (Fig. 4B, eighth panel).
After establishing the correct activation of the executioner
caspases-3, -6, and -7 in LN-18 cells, we analyzed their implica-
tion in the staurosporine-triggered cell death. To this end, we
treated cells for 24 h with staurosporine in the presence or
absence of the pan-caspase inhibitor, q-VD-OPh (qVD). After
staurosporine treatment, and as explained above, the caspase-
mediated cleavages of -fodrin to p120 fragment, lamin A/C to
p47/37 fragments and co-chaperone p23 to p15 fragment were
detected by Western blotting indicating the correct activation
of executioner caspases-3, -6 and -7, respectively. The presence
of qVD completely avoided all these caspase-mediated cleav-
ages (Fig. 5A).
Once we demonstrated that qVD prevented the activation of
caspases in staurosporine-treated LN-18 cells, we took advan-
tage of this compound to assess the relevance of caspases in
triggering cell death. Using the MTT reduction viability assay,
we showed that staurosporine-mediated loss of viability was
almost completely prevented by qVD (from 33.2 to 71.8%) (Fig.
5B, top panel). We also analyzed changes in membrane perme-
ability by measuring the extracellular release of LDH. The
extracellular LDH activity detected after staurosporine treat-
ment (54.06%) was completely absent when cells were
co-treated with qVD (Fig. 5B, middle panel). Additionally, by
using the trypan blue exclusion assay, we confirmed that mem-
brane permeability induced by staurosporine was completely
avoided in the presence of the pan-caspase inhibitor (Fig. 5B,
bottom panel). Finally, we analyzed the role of caspases in the
nuclear morphology in dead LN-18 cells. The stage III chroma-
tin condensation displayed by cells treated with staurosporine
was completely reverted in the presence of qVD (Fig. 5C).
Taken together, our results showed that both cell death and the
nuclear changes observed in staurosporine-treated LN-18 cells
depend on caspase activation.
The Amount of DFF40/CAD Is Not Sufficient to Allow Apo-
ptotic LN-18 Cells to Degrade Their Chromatin into Oligo-
nucleosome-sized Pieces—The activation of the endonuclease
DFF40/CAD is the key caspase-mediated event that allows cells to
proceedwith the final stepsof apoptosis (5, 10, 14, 33). Because the
executioner caspases were correctly activated in staurosporine-
FIGURE 5. LN-18 cells undergo caspase-dependent cell death upon staurosporine challenge. LN-18 cells were treated for 24 h with 1 M STP in the
presence () or absence () of the pan-caspase inhibitor qVD. A, proteins extracts were obtained and electrophoresed.Western blotting against fodrin, lamin
A/C, andp23wasperformed to assess the activationof caspase-3, -6, and -7by thedetectionof p120 (fodrin), p47/p37 (laminA/C), andp15 (p23 co-chaperone)
proteolytic fragments, respectively. Naphthol blue (NB) served as loading control. B, cell viability (measured byMTT reduction assay) and cell death (measured
by LDH release or trypan blue exclusion assays) were assessed. Values represent themeans S.D. (error bars) of three independent experiments. C, cells were
fixed and stained with Hoechst 33258. Representative photographs of each condition (left) and themagnification of the insets (right) are shown. Scale bar, 40m.
FIGURE 6. The inhibitor of DFF40/CAD (ICAD) is correctly processed, and
DFF40/CAD protein levels remain unaltered throughout staurosporine
treatment in LN-18 cells. LN-18 cellswere treatedwith 1MSTP for 2, 4, 6, or
8 h or left untreated (0). Then, cells were collected, and proteins were
extracted by a buffer containing 1% SDS. Western blots against ICAD (A) and
CAD (B) are shown. The resulting fragments of caspase-3-mediated process-
ing of ICAD are illustrated (p24, p18, and p11). Naphthol blue (NB) staining
served as loading control.
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treated LN-18 cells, we studied the activation of DFF40/CAD. To
this end, we analyzed the caspase-3-mediated cleavage of ICAD,
the inhibitor ofDFF40/CAD.We found that the cleavage of ICAD
began 4 h after staurosporine treatment (p30 and p24 fragments,
from long and short isoforms of ICAD, respectively). After 6 h of
treatment, the p11 fragment, corresponding to the C-terminal
fragment of ICADL was also evidenced (Fig. 6A). Moreover,
DFF40/CAD was present well over the time of treatment with
staurosporine (Fig. 6B), excluding the possibility that the defect of
LN-18 cells in undergoing canonical apoptosis was due to degra-
dation of the endonuclease (34). To rule out the possibility of a
potentialmutation indff40/cador icadgenesofLN-18cells affect-
ing the pro-apoptotic function of the endonuclease, the corre-
sponding ORFs were amplified, and the cDNAs obtained were
sequenced in both directions. The results obtained revealed wild-
type sequences compared with the human DFF40/CAD, ICADL,
and ICADSnucleotideconsensus sequences fromtheNCBInucle-
otide database (NM_004402, NM_004401, and NM_213566,
respectively) (data not shown).
At this point, we asked whether the refractoriness of LN-18
cells to display the hallmarks of apoptosis could be due to the
chromatin structure, impairing the endonuclease accessibility
to the internucleosomal sites (22). To answer this question, we
performed a cell-free assay by isolating nuclei and cytosolic
protein extracts from LN-18 or SH-SY5Y cells, SH-SY5Y cells
being a positive control that displays DNA laddering (27). As
shown in Fig. 7, DNA from LN-18 isolated nuclei incubated
with cytoplasms obtained from staurosporine-treated SH-
SY5Y cells was degraded into oligonucleosome-sized pieces
(lane 6). As expected, cytoplasms from staurosporine-treated
LN-18 cells did not provoke DNA laddering on LN-18 isolated
nuclei (lane 8). On the other hand, only cytoplasms from stau-
rosporine-treated SH-SY5Y (lane 2), but not those pertaining
to LN-18 (lane 4) cells, were suitable to induce DNA laddering
on SH-SY5Y isolated nuclei. The absence of DNA laddering in
both supernatants (lanes 13–16) and nuclei washes (lanes
9–12) (see “Experimental Procedures”) corroborated that the
DNA degradation observed in lanes 1 and 6 was actually gen-
erated on the chromatin from isolated nuclei during the in vitro
reaction. Therefore, the absence of DNA laddering in LN-18
cells is due to an alteration in the apoptotic signaling at the
cytosolic level rather than to an intrinsic defect in their
chromatin.
The processing of ICAD by caspase-3, which allows the
release and activation of cytosolic DFF40/CAD, is the main
molecular event that triggers the oligonucleosomal DNA deg-
radation during apoptosis (23). Therefore, we wanted to com-
pare caspase-3 activation and ICADprocessing between LN-18
FIGURE 7. Chromatin of isolated nuclei from LN-18 cells is suitable to be hydrolyzed into oligonucleosome-sized DNA fragments. A, cytoplasms and
nuclei from SH-SY5Y or LN-18 cells were obtained as described under “Experimental Procedures.” The different fractions were mixed as indicated, and the in
vitro reactions were performed according to the cell-free system to detect DNA degradation procedure. Then, DNA was extracted from supernatants (lanes
13–16), nuclei washes (lanes 9–12), or pelleted nuclei (lanes 1–8) and electrophoresed to analyze oligonucleosomal DNA fragmentation.
FIGURE 8. LN-18 cells express lower amount of DFF40/CAD protein com-
paredwithSH-SY5Y cells. SH-SY5Y and LN-18 cellswere seeded and treated
with 1M staurosporine () or left untreated () for 24 h. The cells were then
detached, and total protein extracts were obtained.Western blotting against
caspase-3, ICAD, and CAD was performed. Caspase-3 activation and ICAD
processingwere corroborated by the detection of p19/p17 and p24/p18/p11
fragments, respectively. Note that thebands in the ICAD immunoblotmarked
with (*) are from the previous immunoblot against caspase-3. Naphthol blue
(NB) staining served as loading control.
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and SH-SY5Y cells after staurosporine challenge. As shown in
Fig. 8, the alkaloid induced comparable levels of both cleaved
caspase-3andprocessed ICADinLN-18andSH-SY5Ycells.How-
ever, the total protein levels of DFF40/CADwere dissimilar, being
lower inLN-18cells, consistentwith aDFF40/CAD-deficient con-
stitutive expression in LN-18 cells versus SH-5Y5Y cells.
The Overexpression of hCAD Does Not Enable LN-18 Cells to
Display Stage II Apoptotic Nuclear Morphology after Cytotoxic
Insult Despite Triggering Internucleosomal DNA Fragmen-
tation—Taking into account the results obtained, we stably
transfected LN-18 cells with the eukaryotic expression plasmid
pcDNA3 carrying the ORF of human CAD (hCAD) or with the
FIGURE 9. The overexpression of DFF40/CAD does not enable LN-18 cells to display stage II apoptotic nuclear morphology despite triggering oligo-
nucleosomal DNA fragmentation after cytotoxic insult. A–D, LN-18 cells stably transfected with the human ORF of CAD (hCAD) or with the empty vector
(mock) were treatedwith 1M staurosporine (STP or) or left untreated (Control or). A left, proteinwas extracted fromuntreated cells, andWestern blotting
against CADwas performed to corroborate the overexpression of the endonuclease. Naphthol blue (NB) staining served as loading control. A right, DNA from
staurosporine-treated (6 h) or untreated cells was obtained and processed according to the LMWDNA degradation analysis protocol. B, cells treated (24 h) or
left untreated were fixed and stained with Hoechst 33258. Representative microphotographs of each condition are shown. The right panels are higher magni-
ficationsof thecells framedinthemiddlepanels.Scalebar, 40m.C, thepercentageofcelldeath instaurosporine-treatedoruntreatedcellswascalculatedbycounting
stage I, stage II, or stage III nuclear morphology. The graph represents themeans S.D. (error bars) obtained after counting300 cells in each condition (n 3).D,
representativeelectronmicroscopy images fromcells treatedwith staurosporine for 10h.Scalebars, 2m.E, LN-18cells stably transfectedwithhCADwere treatedas
indicated for 24h. Thecellswere then fixedandstainedwithHoechst 33258. Representativemicrophotographsof eachconditionare shown. The insets framed in the
images are higher magnifications of the cells. Scale bar, 40 m. F, table summarizes cell viability and the stage of apoptotic nuclear morphology observed in
CAD-overexpressingLN-18 cells treatedwithdifferent chemotherapydrugs for 24h. Cell viability,measuredbyMTTassay, is representedas themeansS.D. (n3).
Nuclearmorphologywas scoredas stage I (peripheral chromatin condensation), stage II (nuclear collapse anddisassembly), or stage III (highly compacted chromatin
without signs of karyorrhexis. Minus () and plus () indicate “not detected” and “detected,” respectively.
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empty vector (mock). After corroborating the expression levels
of DFF40/CAD (Fig. 9A, left panel), we treated cells with
staurosporine for 24 h. We found that CAD-overexpressing,
but not mock-transfected, cells displayed internucleosomal
DNA cleavage after staurosporine treatment (Fig. 9A, right
panel). The analysis of the nuclei revealed that the transfection
with the empty vector did not affect the nuclear morphology
observed previously in LN-18-nontransfected cells, including
either staurosporine-treated or nontreated cells (Fig. 9B). Sur-
prisingly, CAD-overexpressing cells showed highly condensed
chromatin without signs of nuclear fragmentation after stauro-
sporine challenge (Fig. 9B). In fact, the percentage of cells dis-
playing nuclear pyknosis and karyorrhexis (stage II nuclear
morphology) never exceeded 3% of the total cell population
(Fig. 9C). Ultrastructurally, staurosporine-treated hCAD-over-
expressing LN-18 cells presented a unique mass of highly con-
densed chromatin, containing small electron-lucent areas. The
nuclear envelope appeared disrupted, whereas the nuclei
remained unfragmented. At the cytoplasmic level, we observed
a heterogeneous content with abundant low dense intrusions
compatible with lipid droplets (Fig. 9D). We obtained the same
results by transient transfection of DFF40/CAD, ruling out a
FIGURE 9—continued
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partial loss of function of the endonuclease over cell culture.
(data not shown).We then sought to explorewhetherCADover-
expression allowed other apoptotic insults to induce stage II
nuclear morphology. None of the cytotoxic drugs, which effec-
tively provoked loss of cell viability in both non-transfected (Fig.
3A and Table 1) and CAD-overexpressing LN-18 cells (Fig. 9F),
induced stage II nuclearmorphology inCAD-overexpressing cells
(Fig. 9, E and F). Therefore, making LN-18 cells express higher
levels of DFF40/CAD is not sufficient to allow apoptotic chroma-
tin fragmentation in cells committed to die.
IsolatedNuclei from LN-18 Cells RemainUnfragmented after
Incubation with Apoptotic Cytoplasms in Vitro—So far, our
results showed the inability of LN-18 cells to display oligo-
nucleosomal DNA degradation during apoptosis, which can be
solved either by DFF40/CAD overexpression or by incubating
isolated nuclei with staurosporine-pretreated cytoplasms from
SH-SY5Y cells. However, overexpression of the endonuclease
was insufficient to generate apoptotic nuclear morphology.
Therefore, we decided to establish a cell-free assay to analyze
nuclear fragmentation.
The nuclei isolated from SH-SY5Y cells responded differen-
tially to cytoplasms from staurosporine-treated SH-SY5Y or
LN-18 cells.When they were incubated with preactivated cyto-
plasms from SH-SY5Y cells, the chromatin adopted a necklace
shape, compatible with an intermediate stage II apoptotic
nuclear morphology (35). However, when incubated with cyto-
FIGURE 10. The refractoriness of LN-18 cells to undergo apoptotic nuclear morphology relies on both nuclear and cytoplasmic impairments. Cyto-
plasms and nuclei from SH-SY5Y or LN-18 cells were obtained as described under “Experimental Procedures.” The different fractions weremixed as indicated,
and the in vitro reactions were performed according to the cell-free system to analyze nuclear morphology procedure. A, after 60 min of in vitro reaction, the
nuclei were fixed with 1% paraformaldehyde and stained with Hoechst 33258. Representative images of each condition are shown. Scale bar, 20 m. B, time
course of cell-free reactions is shown. Representative images of cells fixed and stainedwith Hoechst 33258were obtained at the indicated times. Scale bar, 5m.
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plasms from staurosporine-treated LN-18 cells, SH-SY5Y
nuclei collapsed, showing a chromatin condensation similar to
that observed in LN-18 cells in vivo (Fig. 10A). However, when
LN-18 nuclei were employed, the morphological alterations
observed were noticeably different from those detected in
SH-SY5Y nuclei.When exposed to staurosporine-treated cyto-
plasms from either SH-SY5Y or LN-18 cells, their chromatin
appeared condensed in a continuous ring at the interior surface
of the nuclear envelope, compatible with stage I apoptotic
nuclear morphology. However, whereas LN-18 nuclei exposed
to preactivated cytoplasms from SH-SY5Y cells appeared swol-
len, those incubated with preactivated cytoplasms from LN-18
cells became visiblywrinkly (Fig. 10A). It was noted that after 60
min of in vitro reaction, cytoplasms from untreated SH-SY5Y
or LN-18 cells did not induce any significant change in either
SH-SY5Y or LN-18 isolated nuclei (Fig. 10A).
After an incubation period with SH-SY5Y pre-treated cyto-
plasms, SH-SY5Y nuclei showed different apoptotic stages:
first, small masses of condensed chromatin at 20 min, followed
by a necklace appearance at 60 min, and finally, the fragmenta-
tion of the nucleus after 2 h of in vitro assay (Fig. 10B). When
LN-18 preactivated cytoplasms were used, SH-SY5Y nuclei
progressively shrank, acquiring an aspect resembling the afore-
mentioned stage III apoptotic nuclear morphology. However,
LN-18 nuclei underwent a progressive swelling in the presence
of preactivated cytoplasms from SH-SY5Y cells. The chroma-
tin, although peripherally distributed at the beginning of the
assay (20 and 60min), appearedmicrofragmented after 120min
of in vitro reaction. Similarly, after 20 and 60 min of assay,
LN-18 nuclei mixed with preactivated LN-18 cytoplasms dis-
played peripherally condensed chromatin. However, under
these conditions, LN-18 nuclei suffered a gradual shrinkage
which, after 120 min of reaction, resembled that observed in
SH-SY5Y isolated nuclei after 60 or 120min of incubation with
LN-18 preactivated cytoplasms (Fig. 10B). Altogether, LN-18
cells appear to be equipped with molecular cues to reject com-
pletion of apoptosis. They are localized both in the cytoplasm
and in the nucleus and prevent the preactivated cytoplasm from
promoting the formation of chromatin clumps and support
nuclear chromatin refractoriness to be fragmented.
DISCUSSION
We now describe a new apoptotic behavior depicted by
LN-18 cells, a human glioblastoma-derived cell line. After apo-
ptotic insult, LN-18 cells undergo abortive caspase-dependent
apoptosis in which neither chromatin disassembly nor oligo-
nucleosomal DNA breakdown takes place despite cell death.
The amount of DFF40/CAD is the key event explaining the
refractoriness of LN-18 cells to degrade their genomic content
into oligonucleosome-sized fragments. Indeed, the overexpres-
sion of this endonuclease is sufficient to enable LN-18 cells to
generate DNA laddering after staurosporine treatment. Intrigu-
ingly, the overexpression of this endonuclease does not affect the
nuclear changes observed in wild-type cells after cytotoxic
insult. Moreover, using cell-free in vitro assays we show that
both nuclei and cytoplasm from LN-18 cells behave in an aber-
rant apoptotic fashion. This is the first report on a cellular
model in which DFF40/CAD overexpression makes cells com-
petent for DNA laddering, but does not allow them to undergo
stage II nuclear morphology upon apoptotic insult.
Up until now, three different cellular responses have been
reported as regard the presence or not of the two apoptotic hall-
marks during caspase-dependent cell death: first, cells that display
both stage II nuclear morphology and DNA ladder (e.g. SH-SY5Y
and NB69 cells, among others) (18); second, cells displaying none
of these apoptotic hallmarks (e.g. IMR-5, IMR-32, and LAI-5S
cells) (18, 23, 27); and third, cells showing stage II nuclear mor-
phologybutnotoligonucleosomalDNAbreakdown (e.g.MOLT-4
and SK-N-AS cells) (21, 23). In all cases, cells need functional
DFF40/CAD to display both hallmarks after caspase activation.
Indeed,DFF40/CADknockdownavoids stage IInuclearmorphol-
ogy (revealing stage I nuclear morphology) and oligonucleosomal
DNAdegradation in cells proficient to display anyof the apoptotic
hallmarks (33). In the same sense, the overexpression of this endo-
nuclease is enough to facilitate the apoptotic hallmarks in those
cells that are defective in displaying them (33). In LN-18 cells, as
expected, the overexpression of DFF40/CAD provides the ability
todegrade thechromatin intooligonucleosomal length fragments.
Interestingly, although caspase-dependent, the nuclear morphol-
ogy observed in apoptotic LN-18 cells is not affectedbyDFF40/CAD
overexpression or the specific knockdownof this endonuclease.7
Nuclear shrinkage and disassembly and oligonucleosomal
DNA breakdown during apoptosis were classically considered
to arise concomitantly or, at least, be closely related (16–19).
The close relationship that exists between both apoptotic hall-
marks relied on DFF 40/CAD. In fact, the proper activation of
this endonuclease seems themolecular key bottleneck allowing
cells to display both apoptotic hallmarks after the proteolytic
action of caspases. In neuroblastoma-derived IMR-5 cells, for
example, the disappearance of DFF40/CAD during caspase-de-
pendent apoptosis correlates with the absence of both inter-
nucleosomal DNA cleavage and stage II nuclear morphology,
despite the proper activation of caspase-3 (10, 18, 27). Further-
more, SH-SY5Y cells, a classical cellular model that undergoes
canonical apoptotic cell death, fail to display either of the apo-
ptotic hallmarks after their treatment with high cytotoxic con-
centrations of methadone because of DFF40/CAD proteolysis
(34). The latest reports on some cellular models undergoing
caspase-dependent cell death, characterized by the presence of
stage II nuclear morphology without oligonucleosomal DNA
degradation, suggest a dissociation between both processes
(20–23). However, DFF40/CAD is still required. In this regard,
we have recently reported that the nuclear collapse and disas-
sembly observed during caspase-dependent cell death in SK-N-
AS cells, which fail to degrade their DNA into oligonucleo-
some-sized fragments depend onDFF40/CAD catalytic activity
(33). LN-18 cells although undergoing caspase-dependent cell
death, are unable to degrade their genomic content into
oligonucleosome-sized fragments, irrespectively of the drug
employed. As regards the nuclear aspect after bisbenzimide
staining, and depending on the cytotoxic insult used, injured
LN-18 cells can display either stage I chromatin compaction or
stage II-like nuclear condensation, characterized by showing no
7 M. Sa´nchez-Osuna and V. J. Yuste, unpublished results.
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signs of karyorrhexis. The deficiency of LN-18 cells to show
nuclear fragmentation is not due to improper caspase activa-
tion because both cell demise and the nuclear changes observed
are completely reverted when cells are cultured in the presence
of a pan-caspase inhibitor. It is worth noting that the data
obtained from LN-18 cells show that chromatin packaging and
nuclear disassembly are two processes that can be molecularly
dissociated. Interestingly, this particular apoptotic response
was also observed in other cell lines, such as U87MG or T98G
cells.7
The analysis of the apoptotic behavior of LN-18 cells has
allowed us to add another molecular clue to the controlling of
the nuclear changes during caspase-dependent cell death. In
fact, this is the first report on a cellular model in which the
compaction of the chromatin is independent of the enzymatic
action of DFF40/CAD. Our finding appears to be discordant
with previous data establishing that the alteration of DFF40/
CAD function abolishes both chromatin compaction and
nuclear apoptotic body formation (10, 12, 33, 36, 37). An alter-
native explanation might be that DFF40/CAD-mediated apo-
ptotic signaling is necessary but not sufficient to induce the
complete chromatin reorganization during apoptosis, and
other DFF40/CAD-independent intracellular pathways are
involved. The packaging of the chromatin during apoptosis is a
dynamic process. Besides DFF40/CAD, some other molecules
have emerged as additional factors that influence apoptotic
nuclear packaging (38). Acinus, upon caspase-3 cleavage,
induces chromatin condensation in a cell-free system (39).
Conversely, the knockdownof acinus does not impede chroma-
tin packaging during apoptotic cell death (40). Thus, the role of
thismolecule in apoptotic nuclear shrinkage is still unclear. The
actin dynamics is another factor influencing cell shape and
nuclear changes during apoptosis. Widlak and colleagues have
shown that inhibitors of actin depolymerization reduce chro-
matin condensation, but not DNA fragmentation, in cultured
cells undergoing apoptosis (41). In another work,Wakabayashi
and collaborators showed that physicochemical states of actin
play a role in the execution phase of apoptotic processes (42).
Indeed, the addition of jasplakinolide, a stabilizer of F-actin, or
latrunculinA, a destabilizer of F-actin, to the culturemediumof
injured cells, prevents cell fragmentation, nuclear pyknosis, and
karyorrhexis (42). However, the alteration of actin dynamics
does not allow distinguishing between apoptotic chromatin
package and nuclear fragmentation processes. Indeed, there are
no data so far reported on whether DNA compaction and
nuclear disassembly can occur separately, and it is considered
that they both arise concomitantly during the last stage of
nuclear changes (35). Here, we have identified LN-18 cells,
which undergo distinctive nuclear changes during caspase-de-
pendent cell death. The microscopic aspect of bisbenzimide-
stained nuclei fromLN-18 cells treatedwith different apoptotic
agents shows that the genomic content becomes compacted in
a uniquemass, without chromatin clumps of smaller size. How-
ever, the ultrastructural analysis of staurosporine-treated
LN-18 cells reveals the presence of chromatin-free intracellular
bodies, surrounded by a double membrane, which are compat-
ible with the buds observed during apoptotic nuclear fragmen-
tation (43). The presence of such condensed chromatin-free
structures in injured LN-18 cells suggests the existence of an
unknown mechanism regulating the maintenance of the pack-
aged chromatin in nuclear apoptotic bodies. Interestingly, the
presence of condensed chromatin inside the nuclear buds is
independent of double-strand oligonucleosomal DNA frag-
mentation because vDFF40/CAD-overexpressing LN-18 cells
are still unable to undergo stage II nuclear morphology after
apoptotic insult. Thus, the molecular mechanisms governing
the deposition of the packaged chromatin into the apoptotic
nuclear bodies aremore intricate than initially expected.More-
over, although closely interconnected, the molecular players
controlling apoptotic chromatin fragmentation, compaction
and deposition into nuclear apoptotic bodies should be distinct.
Supporting this idea, the chromatin of isolated nuclei from
LN-18 cells is able to be degraded into oligonucleosomal length
DNA pieces by a competent apoptotic cytoplasm and yet
unable to become packaged into the apoptotic nuclear bodies.
In summary, the DFF40/CAD-independent apoptotic phe-
notype observed in LN-18 cells after cytotoxic insult unveils a
novel unexplored avenue for caspase-dependent cell death. The
consequences of the so far untested cell death paradigm are of
biological significance, given the relevance of correct cell dis-
mantling in avoiding undesirable pathophysiological effects.
Indeed, the phenotypic aspect of an apoptotic cell has been of
special interest because defective or abortive apoptosis repre-
sents a major causative factor in the development and progres-
sion of cancer (44, 45). A correct genomic content packaging of
a cell committed to die wouldminimize the spreading of harm-
ful genes, such as oncogenes or viral DNA. In this context,
extracellular DNA from dead cells can activate intracellular
pathways in living “receptor” cells, leading to disparate conse-
quences that range from cytotoxicity to cellular transformation
(46, 47). Therefore, knowing how chromatin collapse and
nuclear disassembly are regulated during caspase-dependent
apoptosis could be instrumental for understanding the intimate
mechanism that governs an accurate and silent non-harmful
cell death. Hence, LN-18 cells are a valuable tool to dissect the
biochemical mechanisms that stepwise govern apoptotic chro-
matin compaction and its final deposition into the apoptotic
nuclear bodies.
Acknowledgments—We thank the Personnel of Servei de Microscopia
and Servei de Geno`mica i Bioinforma`tica, Universitat Auto`noma de
Barcelona; all other members of the laboratory for helpful criticisms;
Laura Martínez-Escardo´ and Ricard Canals-Florit for contribution
to the sequencing of ICAD isoforms; and to Dr. Rafaela Can˜ete-Soler
for reading the manuscript.
REFERENCES
1. Lecoeur, H. (2002) Nuclear apoptosis detection by flow cytometry: influ-
ence of endogenous endonucleases. Exp. Cell Res. 277, 1–14
2. Susin, S. A., Daugas, E., Ravagnan, L., Samejima, K., Zamzami, N., Loeffler,
M., Costantini, P., Ferri, K. F., Irinopoulou, T., Pre´vost,M. C., Brothers, G.,
Mak, T. W., Penninger, J., Earnshaw, W. C., and Kroemer, G. (2000) Two
distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192, 571–580
3. Wyllie, A.H.,Morris, R.G., Smith, A. L., andDunlop,D. (1984)Chromatin
cleavage in apoptosis: association with condensed chromatinmorphology
and dependence on macromolecular synthesis. J. Pathol. 142, 67–77
4. Zamzami, N., and Kroemer, G. (1999) Condensed matter in cell death.
Lack of Apoptotic Chromatin Clumps after CADOverexpression
JULY 4, 2014•VOLUME 289•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 18767
 at U
A
B/FA
C. M
ED
ICIN
A
 on July 6, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Nature 401, 127–128
5. Liu, X., Zou, H., Slaughter, C., andWang, X. (1997) DFF, a heterodimeric
protein that functions downstream of caspase-3 to trigger DNA fragmen-
tation during apoptosis. Cell 89, 175–184
6. Walker, P. R., and Sikorska, M. (1997) New aspects of the mechanism of
DNA fragmentation in apoptosis. Biochem. Cell Biol. 75, 287–299
7. Riedl, S. J., and Shi, Y. (2004)Molecular mechanisms of caspase regulation
during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897–907
8. Pop, C., and Salvesen, G. S. (2009) Human caspases: activation, specificity,
and regulation. J. Biol. Chem. 284, 21777–21781
9. Elmore, S. (2007) Apoptosis: a review of programmed cell death. Toxicol.
Pathol. 35, 495–516
10. Yuste, V. J., Sa´nchez-Lo´pez, I., Sole´, C., Moubarak, R. S., Bayascas, J. R.,
Dolcet, X., Encinas, M., Susin, S. A., and Comella, J. X. (2005) The contri-
bution of apoptosis-inducing factor, caspase-activated DNase, and inhib-
itor of caspase-activated DNase to the nuclear phenotype and DNA deg-
radation during apoptosis. J. Biol. Chem. 280, 35670–35683
11. Wlodkowic, D., Telford, W., Skommer, J., and Darzynkiewicz, Z. (2011)
Apoptosis and beyond: cytometry in studies of programmed cell death.
Methods Cell Biol. 103, 55–98
12. Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W. T., and Wang, X.
(1998) The 40-kDa subunit of DNA fragmentation factor induces DNA
fragmentation and chromatin condensation during apoptosis. Proc. Natl.
Acad. Sci. U.S.A. 95, 8461–8466
13. Halenbeck, R., MacDonald, H., Roulston, A., Chen, T. T., Conroy, L., and
Williams, L. T. (1998) CPAN, a human nuclease regulated by the caspase-
sensitive inhibitor DFF45. Curr. Biol. 8, 537–540
14. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Na-
gata, S. (1998) A caspase-activated DNase that degrades DNAduring apo-
ptosis, and its inhibitor ICAD. Nature 391, 43–50
15. Sakahira, H., Enari,M., andNagata, S. (1998) Cleavage of CAD inhibitor in
CAD activation and DNA degradation during apoptosis. Nature 391,
96–99
16. Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267,
1445–1449
17. Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death
in animal development. Cell 88, 347–354
18. Boix, J., Llecha, N., Yuste, V. J., and Comella, J. X. (1997) Characterization
of the cell death process induced by staurosporine in human neuroblas-
toma cell lines. Neuropharmacology 36, 811–821
19. Samejima, K., Tone, S., and Earnshaw,W. C. (2001) CAD/DFF40 nuclease
is dispensable for high molecular weight DNA cleavage and stage I chro-
matin condensation in apoptosis. J. Biol. Chem. 276, 45427–45432
20. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A.,
Wakeling, A. E., Walker, P. R., and Sikorska, M. (1993) Apoptotic death in
epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or
in the absence of internucleosomal fragmentation. EMBO J. 12,
3679–3684
21. Falcieri, E., Martelli, A. M., Bareggi, R., Cataldi, A., and Cocco, L. (1993)
The protein kinase inhibitor staurosporine induces morphological
changes typical of apoptosis in MOLT-4 cells without concomitant DNA
fragmentation. Biochem. Biophys. Res. Commun. 193, 19–25
22. Kuribayashi, N., Sakagami, H., Iida,M., and Takeda,M. (1996) Chromatin
structure and endonuclease sensitivity in human leukemic cell lines. An-
ticancer Res. 16, 1225–1230
23. Iglesias-Guimarais, V., Gil-Guin˜on, E., Gabernet, G., García-Belinchon,
M., Sa´nchez-Osuna, M., Casanelles, E., Comella, J. X., and Yuste, V. J.
(2012) Apoptotic DNAdegradation into oligonucleosomal fragments, but
not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/
CAD endonuclease. J. Biol. Chem. 287, 7766–7779
24. Gozzelino, R., Sole, C., Llecha, N., Segura, M. F., Moubarak, R. S., Iglesias-
Guimarais, V., Perez-Garcia, M. J., Reix, S., Zhang, J., Badiola, N., Sanchis,
D., Rodriguez-Alvarez, J., Trullas, R., Yuste, V. J., and Comella, J. X. (2008)
BCL-XL regulates TNF--mediated cell death independently of NF-B,
FLIP and IAPs. Cell Res. 18, 1020–1036
25. Decker, T., and Lohmann-Matthes, M. L. (1988) A quick and simple
method for the quantitation of lactate dehydrogenase release in measure-
ments of cellular cytotoxicity and tumor necrosis factor (TNF) activity.
J. Immunol. Methods 115, 61–69
26. Ribas, J., Yuste, V. J., Garrofe´-Ochoa, X., Meijer, L., Esquerda, J. E., and
Boix, J. (2008) 7-Bromoindirubin-3-oxime uncovers a serine protease-
mediated paradigmof necrotic cell death.Biochem. Pharmacol. 76, 39–52
27. Yuste, V. J., Bayascas, J. R., Llecha, N., Sa´nchez-Lo´pez, I., Boix, J., and
Comella, J. X. (2001) The absence of oligonucleosomal DNA fragmenta-
tion during apoptosis of IMR-5 neuroblastoma cells: disappearance of the
caspase-activated DNase. J. Biol. Chem. 276, 22323–22331
28. Boix, J., Fibla, J., Yuste, V., Piulats, J. M., Llecha, N., and Comella, J. X.
(1998) Serum deprivation and protein synthesis inhibition induce two
different apoptotic processes in N18 neuroblastoma cells. Exp. Cell Res.
238, 422–429
29. Ja¨nicke, R. U., Ng, P., Sprengart, M. L., and Porter, A. G. (1998) Caspase-3
is required for -fodrin cleavage but dispensable for cleavage of other
death substrates in apoptosis. J. Biol. Chem. 273, 15540–15545
30. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M.
(1996) The CED-3/ICE-like protease Mch2 is activated during apoptosis
and cleaves the death substrate lamin A. J. Biol. Chem. 271, 16443–16446
31. Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T.,
Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H.,
and Earnshaw, W. C. (1996) Cleavage of lamin A by Mch2 but not
CPP32: multiple interleukin 1-converting enzyme-related proteases
with distinct substrate recognition properties are active in apoptosis. Proc.
Natl. Acad. Sci. U.S.A. 93, 8395–8400
32. Walsh, J. G., Cullen, S. P., Sheridan, C., Lu¨thi, A. U., Gerner, C., and
Martin, S. J. (2008) Executioner caspase-3 and caspase-7 are functionally
distinct proteases. Proc. Natl. Acad. Sci. U.S.A. 105, 12815–12819
33. Iglesias-Guimarais, V., Gil-Guin˜on, E., Sa´nchez-Osuna,M., Casanelles, E.,
García-Belinchon, M., Comella, J. X., and Yuste, V. J. (2013) Chromatin
collapse during caspase-dependent apoptotic cell death requires DNA
fragmentation factor, 40-kDa subunit-/caspase-activated deoxyribonu-
clease-mediated 3-OH single-strand DNA breaks. J. Biol. Chem. 288,
9200–9215
34. Perez-Alvarez, S., Iglesias-Guimarais, V., Solesio, M. E., Melero-Fernan-
dez de Mera, R. M., Yuste, V. J., Galindo, M. F., and Jorda´n, J. (2011)
Methadone induces CAD degradation and AIF-mediated necrotic-like
cell death in neuroblastoma cells. Pharmacol. Res. 63, 352–360
35. Tone´, S., Sugimoto, K., Tanda, K., Suda, T., Uehira, K., Kanouchi, H.,
Samejima, K., Minatogawa, Y., and Earnshaw,W. C. (2007) Three distinct
stages of apoptotic nuclear condensation revealed by time-lapse imaging,
biochemical and electron microscopy analysis of cell-free apoptosis. Exp.
Cell Res. 313, 3635–3644
36. Zhang, J., Wang, X., Bove, K. E., and Xu, M. (1999) DNA fragmentation
factor 45-deficient cells are more resistant to apoptosis and exhibit differ-
ent dying morphology than wild-type control cells. J. Biol. Chem. 274,
37450–37454
37. Widlak, P. (2000) TheDFF40/CADendonuclease and its role in apoptosis.
Acta Biochim. Polon. 47, 1037–1044
38. Samejima, K., Tone´, S., Kottke, T. J., Enari, M., Sakahira, H., Cooke, C. A.,
Durrieu, F., Martins, L. M., Nagata, S., Kaufmann, S. H., and Earnshaw,
W. C. (1998) Transition from caspase-dependent to caspase-independent
mechanisms at the onset of apoptotic execution. J. Cell Biol. 143, 225–239
39. Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., and Tsujimoto,
Y. (1999) Acinus is a caspase-3-activated protein required for apoptotic
chromatin condensation. Nature 401, 168–173
40. Joselin, A. P., Schulze-Osthoff, K., and Schwerk, C. (2006) Loss of acinus
inhibits oligonucleosomal DNA fragmentation but not chromatin con-
densation during apoptosis. J. Biol. Chem. 281, 12475–12484
41. Widlak, P., Palyvoda, O., Kumala, S., and Garrard, W. T. (2002) Modeling
apoptotic chromatin condensation in normal cell nuclei: requirement for
intranuclear mobility and actin involvement. J. Biol. Chem. 277,
21683–21690
42. Majczak, A., Karbowski, M., Kaminski, M., Masaoka, M., Kurono, C., Ni-
emczyk, E., Kedzior, J., Soji, T., Knap, D., Hallmann, A., andWakabayashi,
T. (2004) Modification of physicochemical properties of actin filaments
suppresses cell fragmentation in the execution phase of staurosporine-
induced apoptotic processes. J. Electron Microsc. 53, 635–647
43. Dini, L., Coppola, S., Ruzittu, M. T., and Ghibelli, L. (1996) Multiple path-
Lack of Apoptotic Chromatin Clumps after CADOverexpression
18768 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 27•JULY 4, 2014
 at U
A
B/FA
C. M
ED
ICIN
A
 on July 6, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ways for apoptotic nuclear fragmentation. Exp. Cell Res. 223, 340–347
44. Kasibhatla, S., and Tseng, B. (2003) Why target apoptosis in cancer treat-
ment?Mol. Cancer Ther. 2, 573–580
45. de Bruin, E. C., and Medema, J. P. (2008) Apoptosis and non-apoptotic
deaths in cancer development and treatment response.Cancer Treat. Rev.
34, 737–749
46. Ermakov, A. V., Konkova, M. S., Kostyuk, S. V., Izevskaya, V. L., Baranova,
A., andVeiko,N.N. (2013)Oxidized extracellularDNAas a stress signal in
human cells. Oxid. Med. Cell. Longev. 2013, 649747
47. Glebova, K., Veiko,N., Kostyuk, S., Izhevskaya, V., andBaranova, A. (2013)
Oxidized extracellular DNA as a stress signal that maymodify response to
anticancer therapy. Cancer Lett. 10.1016/j.canlet. 2013.09.005
Lack of Apoptotic Chromatin Clumps after CADOverexpression
JULY 4, 2014•VOLUME 289•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 18769
 at U
A
B/FA
C. M
ED
ICIN
A
 on July 6, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
